Article

The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol

Department of Pharmacology, Tokyo Women's Medical University School of Medicine, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
Nature Cell Biology (Impact Factor: 19.68). 10/2008; 10(11):1349-55. DOI: 10.1038/ncb1794
Source: PubMed

ABSTRACT

A large number of macrophages and haematopoietic progenitor cells accumulate in pre-metastatic lungs in which chemoattractants, such as S100A8 and S100A9, are produced by distant primary tumours serving as metastatic soil. The exact mechanism by which these chemoattractants elicit cell accumulation is not known. Here, we show that serum amyloid A (SAA) 3, which is induced in pre-metastatic lungs by S100A8 and S100A9, has a role in the accumulation of myeloid cells and acts as a positive-feedback regulator for chemoattractant secretion. We also show that in lung endothelial cells and macrophages, Toll-like receptor (TLR) 4 acts as a functional receptor for SAA3 in the pre-metastatic phase. In our study, SAA3 stimulated NF-kappaB signalling in a TLR4-dependent manner and facilitated metastasis. This inflammation-like state accelerated the migration of primary tumour cells to lung tissues, but this was suppressed by the inhibition of either TLR4 or SAA3. Thus, blocking SAA3-TLR4 function in the pre-metastatic phase could prove to be an effective strategy for the prevention of pulmonary metastasis.

Download full-text

Full-text

Available from: Sachie Ishibashi, Feb 11, 2015
  • Source
    • "The upregulation of Saa3 on monocytes/macrophages highlights the relevance of an inflammatory microenvironment in leukemia engraftment and progression. SAA3 is known to attract monocytes/macrophages, and it may cooperate with inter- leukin-10 (IL-10) to promote M2-skewed macrophage accumulation (Hao et al., 2012; Hiratsuka et al., 2008; Mantovani et al., 2004), ultimately attracting leukemic cells. Notably, we found several chemokines (e.g., CCL2, CCL17, and CCL22) upregulated in leukemic MEC1 cells consistent with previous gene expression studies of leukemic cells from CLL patients (Burger et al., 2009; Herishanu et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The role of monocytes/macrophages in the development and progression of chronic lymphocytic leukemia (CLL) is poorly understood. Transcriptomic analyses show that monocytes/macrophages and leukemic cells cross talk during CLL progression. Macrophage depletion impairs CLL engraftment, drastically reduces leukemic growth, and favorably impacts mouse survival. Targeting of macrophages by either CSF1R signaling blockade or clodrolip-mediated cell killing has marked inhibitory effects on established leukemia also. Macrophage killing induces leukemic cell death mainly via the TNF pathway and reprograms the tumor microenvironment toward an antitumoral phenotype. CSF1R inhibition reduces leukemic cell load, especially in the bone marrow, and increases circulating CD20+ leukemic cells. Accordingly, co-targeting TAMs and CD20-expressing leukemic cells provides a survival benefit in the mice. These results establish the important role of macrophages in CLL and suggest therapeutic strategies based on interfering with leukemia-macrophage interactions.
    Full-text · Article · Feb 2016 · Cell Reports
  • Source
    • "Many attempts have been made to identify new reagents that may control innate immune reactions [1]–[4]. Although the innate immune system protects the host from continual attacks by pathogens, inflammatory responses may lead to unwanted consequences, such as rheumatoid arthritis [5], [6], diabetes [7], [8], or tumor metastasis [9]–[12], in some cases. Recent studies designated such an imbalance of inflammatory reactions as “homeostatic inflammation”, and suggested that the containment of inflammatory cytokines by neutralizing antibodies may prevent the formation of the pre-metastatic phase in the tumor metastasis process [13]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Celastramycin A, a small molecule that inhibits the production of antibacterial peptides in an ex vivo culture system of Drosophila, suppresses the TNFα-mediated induction of IL-8 in mammalian cells. To understand its molecular mechanism, we examined Celastramycin A binding proteins and investigated their biological functions. Our screening and subsequent pull-down assay revealed ZFC3H1 (also known as CCDC131 or CSRC2), an uncharacterized zinc finger protein, as a Celastramycin A binding protein. The knockdown of ZFC3H1 reduced IL-8 expression levels in the TNFα-stimulated lung carcinoma cell line, LU99, and UV-irradiated HeLa cells. Based on reporter assay results, we concluded that ZFC3H1 participates in the transcriptional activation of IL-8. The findings of our UV-irradiation experiments implied that ZFC3H1 may indirectly interact with ERCC1 in an activated DNA repair complex. Thus, we designated ZFC3H1 as a mammalian target of Celastramycin A (mTOC).
    Full-text · Article · Sep 2014 · PLoS ONE
  • Source
    • "S100A8, S100A9 and SAA3 are TLR4 agonists and induce the activation of MyD88- dependent pathways as well as ERK1/2, p38, mitogenactivated protein kinase (MAPK), c-Jun N-terminal kinase (JNK) and protein kinase C (PKC). Stimulation of TLR4 induces the release of proinflammatory cytokines, chemokines and reactive oxygen species necessary for the activation of potent host defences (Ehrchen et al., 2009; Hiratsuka et al., 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cryptococcus neoformans is a significant cause of fungal meningitis in patients with impaired T cell-mediated immunity (CMI). Experimental pulmonary infection with a C. neoformans strain engineered to produce interferon-gamma, H99γ, results in the induction of Th1-type CMI, resolution of the acute infection, and protection against challenge with wild type (WT) Cryptococcus. Considering that individuals with suppressed T CMI are highly susceptible to pulmonary C. neoformans infection, we sought to determine whether or not antimicrobial peptides were produced in mice inoculated with H99γ. Thus, we measured the levels of antimicrobial peptides Lipocalin-2, S100A8, S100A9, calprotectin (S100A8/A9 heterodimer), serum amyloid A-3 (SAA3), and their putative receptors TLR4 and the receptor for advanced glycation end products [RAGE] in mice during primary and recall responses against C. neoformans infection. Results showed increased levels of IL-17A and IL-22, cytokines known to modulate antimicrobial peptide production. We also observed increased levels of Lipocalin-2, S100A8, S100A9, and SAA3 as well as TLR4+ and RAGE+ macrophages and dendritic cells in mice inoculated with H99γ compared to WT H99. Similar results were observed in the lungs of H99γ-immunized, compared to heat-killed C. neoformans-immunized, mice following challenge with WT yeast. However, IL-22 deficient mice inoculated with H99γ demonstrated antimicrobial peptide production and no change in survival rates compared to WT mice. These studies demonstrate that protection against cryptococcosis is associated with increased production of antimicrobial peptides in the lungs of protected mice that are not solely in response to IL-17A and IL-22 production and may be coincidental rather than functional.
    Full-text · Article · Apr 2014 · Microbiology
Show more